What's Hot
View all perspectives
Mrinalini Dey DrMiniDey
4 years ago
Neighbourhood characteristics & socioeconomic factors important not only for contracting #COVID19 but also severe infection in #SLE. Results useful for developing strategies to address socioeconomic stressors in this population.
Abs#0984 #ACR20 @RheumNow
https://t.co/u4YDcfEcSQ
Richard Conway RichardPAConway
4 years ago
Dan Kastner quoting Clement Clark Moore "visions of sugar plums dancing in our heads" looking forward to the new era of molecular taxonomy of rheumatic disease heralded by the discovery of VEXAS #ACR20 @rheumnow
Dr. John Cush RheumNow
4 years ago
Test your knowledge of day 2 of the #ACR20 meeting. Take our daily ACR IQ quiz and see where you stack up on the leaderboard.
https://t.co/8O5vN9Uto5 https://t.co/tx32siM7a3
Dr. John Cush RheumNow
4 years ago
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @bmsnews, @HorizonNews, @SanofiGenzyme, @Novartis. All content chosen by RheumNow & its Faculty.
Combo Therapy v Monotherapy (SEAM-RA Trial): Dr. Richard Conway
Dr. Conway discusses ACR abstract #0939 presented Saturday at the 2020 ACR annual meeting.
E. Sloan esloanmd
4 years ago
Fascinating and engaging talk by Dr. Kastner on the discovery of VEXAS using a genotype-first strategy. Definitely one to go back and watch if you missed it! #ACR20 https://t.co/D090V7HiG2
Treatment of Dermatomyositis Studies: Dr Robert Chao
Dr. Robert Chao reviews two important abstracts - #0955 (IVIg) and #0958 (tocilizumab) - on the treatment of dermatomyositis as presented at the 2020 ACR annual meeting.
Richard Conway RichardPAConway
4 years ago
Dan Kastner giving an absolute tour de force of the discovery of VEXAS in autoinflammatory diseases: mechanisms and management session now. If you aren't listening, watch it back! #ACR20 @rheumnow https://t.co/zell5e2Brt
sheila RHEUMarampa
4 years ago
Older patients with polypharmacy are at ⬆ risk for drug-drug reactions and adverse effects. @RheumNow #ACR20 https://t.co/uKsYO9B8PZ
Sole RetamozoSole
4 years ago
Management of elderly patients with rheumatic diseases. Dr Rajasimhan. #ACR20 @RheumNow. Also we are near of first therapeutic recommendations of elderly #sjogren syndrome @ramos_casals @p_brito_zeron https://t.co/yjGrSTWV1K
Robert B Chao, MD doctorRBC
4 years ago
Ultrasound to assess synovial-entheses junction correlated with clinical findings Abs#0311
Do you use MSK US in your clinic? @RheumNow #ACR20
Richard Conway RichardPAConway
4 years ago
Dr Khanna presents RECIPE RCT of MMF to reduce immunogenicity of pegloticase. Sustained urate response ≤6mg/dL at 24 weeks 68% with MMF compared to 30% in placebo. @rheumnow #ACR20 Abstr#952 #ACRbest https://t.co/64nN5AqK3W
Dr. Antoni Chan synovialjoints
4 years ago
With the COVID-19 pandemic has this changed our acceptance of telemedicine (TM)? This study from 2018 suggest that tech may be limited to certain demographics and follow up patients more likely to accept TM @RheumNow #ACR20 Abstr#0569
Bella Mehta bella_mehta
4 years ago
Excellent session on #autoinflammatory syndromes #SAPHO syndrome -IL-1 role in disease pathogenesis and something that I ve not come across clinically #Majeed Syndrome @RheumNow #ACR20 #3S038 https://t.co/vnfjPD6Zx9
What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay
Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at the ACR 2020 annual meeting, reviewing two previous clinical trials that also looked at this question and offering his perspective.
Poster Hall